AKOUSTIS TECHNOLOGIES INC (AKTS)

US00973N1028 - Common Stock

0.0372  0 (-9.05%)

After market: 0.0177 -0.02 (-52.42%)

Fundamental Rating

1

Taking everything into account, AKTS scores 1 out of 10 in our fundamental rating. AKTS was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of AKTS have multiple concerns. While showing a medium growth rate, AKTS is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

AKTS had negative earnings in the past year.
In the past year AKTS has reported a negative cash flow from operations.
In the past 5 years AKTS always reported negative net income.
AKTS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -268.85%, AKTS is doing worse than 98.40% of the companies in the same industry.
Industry RankSector Rank
ROA -268.85%
ROE N/A
ROIC N/A
ROA(3y)-106.7%
ROA(5y)-81.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 15.97%, AKTS is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for AKTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

AKTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AKTS has been increased compared to 1 year ago.
Compared to 5 years ago, AKTS has more shares outstanding
The debt/assets ratio for AKTS is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -14.34, we must say that AKTS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -14.34, AKTS is doing worse than 96.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.34
ROIC/WACCN/A
WACC2.38%

2.3 Liquidity

A Current Ratio of 0.32 indicates that AKTS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.32, AKTS is doing worse than 98.40% of the companies in the same industry.
AKTS has a Quick Ratio of 0.32. This is a bad value and indicates that AKTS is not financially healthy enough and could expect problems in meeting its short term obligations.
AKTS has a worse Quick ratio (0.28) than 97.60% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.28

6

3. Growth

3.1 Past

The earnings per share for AKTS have decreased strongly by -49.48% in the last year.
AKTS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.97%.
The Revenue has been growing by 80.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-49.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85%
Revenue 1Y (TTM)2.97%
Revenue growth 3Y60.53%
Revenue growth 5Y80.23%
Sales Q2Q%28.92%

3.2 Future

AKTS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.01% yearly.
AKTS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.27% yearly.
EPS Next Y42.58%
EPS Next 2Y20.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.7%
Revenue Next 2Y34.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

AKTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AKTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AKTS's earnings are expected to grow with 20.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.01%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AKTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AKOUSTIS TECHNOLOGIES INC

NASDAQ:AKTS (12/17/2024, 8:40:32 PM)

After market: 0.0177 -0.02 (-52.42%)

0.0372

0 (-9.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)02-11 2025-02-11/amc
Inst Owners14.98%
Inst Owner Change-7.16%
Ins Owners2.52%
Ins Owner Change0%
Market Cap5.75M
Analysts45.71
Price Target0.26 (598.92%)
Short Float %3.36%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.68%
Min Revenue beat(2)-21.61%
Max Revenue beat(2)10.25%
Revenue beat(4)1
Avg Revenue beat(4)-6.71%
Min Revenue beat(4)-21.61%
Max Revenue beat(4)10.25%
Revenue beat(8)1
Avg Revenue beat(8)-5%
Revenue beat(12)1
Avg Revenue beat(12)-5.68%
Revenue beat(16)3
Avg Revenue beat(16)-3.56%
PT rev (1m)-60%
PT rev (3m)-66.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.3%
EPS NY rev (1m)-14.29%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-28.98%
Revenue NY rev (1m)-2.26%
Revenue NY rev (3m)-2.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.42
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.19
BVpS-0.42
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -268.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.97%
FCFM N/A
ROA(3y)-106.7%
ROA(5y)-81.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.99%
Cap/Sales 6.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.28
Altman-Z -14.34
F-Score3
WACC2.38%
ROIC/WACCN/A
Cap/Depr(3y)199.27%
Cap/Depr(5y)237.78%
Cap/Sales(3y)97.95%
Cap/Sales(5y)207.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85%
EPS Next Y42.58%
EPS Next 2Y20.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.97%
Revenue growth 3Y60.53%
Revenue growth 5Y80.23%
Sales Q2Q%28.92%
Revenue Next Year29.7%
Revenue Next 2Y34.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.97%
OCF growth 3YN/A
OCF growth 5YN/A